A recent study published in the December issue of the Journal of Gastroenterology and Hepatology highlights Vonoprazan's ...

Stifel analysts have maintained a Buy rating and a $28.00 price target for Phathom Pharmaceuticals (NASDAQ:PHAT), focusing on the company's recent developments. Currently trading at $5.59, ...

Vonoprazan will be made available in 10mg and 20mg strengths. A potassium-competitive acid blocker (P-CAB), the drug differs ...

The US regulator has cleared two therapies based on Phathom's acid blocker vonoprazan in combination with antibiotics for Helicobacter pylori infections , which are associated with peptic ulcer ...

Vonoprazan 20mg (1 tab), amoxicillin 500mg (1 cap), clarithromycin 500mg (1 tab); per pack. Vonoprazan suppresses basal and stimulated gastric acid secretion at the secretory surface of the ...